Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cephalosporin Drugs Market, by Generation
1.4.2 Global Cephalosporin Drugs Market, by Application
1.4.3 Global Cephalosporin Drugs Market, by Route of Administration
1.4.4 Global Cephalosporin Drugs Market, by Type
1.4.5 Global Cephalosporin Drugs Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Cephalosporin Drugs Market by Generation
3.1 Global First-Generation Cephalosporin Drugs Market by Region
3.2 Global Second-Generation Cephalosporin Drugs Market by Region
3.3 Global Third-Generation Cephalosporin Drugs Market by Region
3.4 Global Fourth-Generation Cephalosporin Drugs Market by Region
3.5 Global Fifth-Generation Cephalosporin Drugs Market by Region
Chapter 4. Global Cephalosporin Drugs Market by Application
4.1 Global Respiratory Tract Infection Market by Region
4.2 Global Skin Infection Market by Region
4.3 Global Ear Infection Market by Region
4.4 Global Sexually Transmitted Infection Market by Region
4.5 Global Others Market by Region
Chapter 5. Global Cephalosporin Drugs Market by Route of Administration
5.1 Global Injections Market by Region
5.2 Global Oral Drugs Market by Region
Chapter 6. Global Cephalosporin Drugs Market by Type
6.1 Global Branded Market by Region
6.2 Global Generic Market by Region
Chapter 7. Global Cephalosporin Drugs Market by Region
7.1 North America Cephalosporin Drugs Market
7.1.1 North America Cephalosporin Drugs Market by Generation
7.1.1.1 North America First-Generation Cephalosporin Drugs Market by Country
7.1.1.2 North America Second-Generation Cephalosporin Drugs Market by Country
7.1.1.3 North America Third-Generation Cephalosporin Drugs Market by Country
7.1.1.4 North America Fourth-Generation Cephalosporin Drugs Market by Country
7.1.1.5 North America Fifth-Generation Cephalosporin Drugs Market by Country
7.1.2 North America Cephalosporin Drugs Market by Application
7.1.2.1 North America Respiratory Tract Infection Market by Country
7.1.2.2 North America Skin Infection Market by Country
7.1.2.3 North America Ear Infection Market by Country
7.1.2.4 North America Sexually Transmitted Infection Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Cephalosporin Drugs Market by Route of Administration
7.1.3.1 North America Injections Market by Country
7.1.3.2 North America Oral Drugs Market by Country
7.1.4 North America Cephalosporin Drugs Market by Type
7.1.4.1 North America Branded Market by Country
7.1.4.2 North America Generic Market by Country
7.1.5 North America Cephalosporin Drugs Market by Country
7.1.5.1 USA Cephalosporin Drugs Market
7.1.5.1.1 USA Cephalosporin Drugs Market by Generation
7.1.5.1.2 USA Cephalosporin Drugs Market by Application
7.1.5.1.3 USA Cephalosporin Drugs Market by Route of Administration
7.1.5.1.4 USA Cephalosporin Drugs Market by Type
7.1.5.2 Canada Cephalosporin Drugs Market
7.1.5.2.1 Canada Cephalosporin Drugs Market by Generation
7.1.5.2.2 Canada Cephalosporin Drugs Market by Application
7.1.5.2.3 Canada Cephalosporin Drugs Market by Route of Administration
7.1.5.2.4 Canada Cephalosporin Drugs Market by Type
7.1.5.3 Mexico Cephalosporin Drugs Market
7.1.5.3.1 Mexico Cephalosporin Drugs Market by Generation
7.1.5.3.2 Mexico Cephalosporin Drugs Market by Application
7.1.5.3.3 Mexico Cephalosporin Drugs Market by Route of Administration
7.1.5.3.4 Mexico Cephalosporin Drugs Market by Type
7.1.5.4 Rest of North America Cephalosporin Drugs Market
7.1.5.4.1 Rest of North America Cephalosporin Drugs Market by Generation
7.1.5.4.2 Rest of North America Cephalosporin Drugs Market by Application
7.1.5.4.3 Rest of North America Cephalosporin Drugs Market by Route of Administration
7.1.5.4.4 Rest of North America Cephalosporin Drugs Market by Type
7.2 Europe Cephalosporin Drugs Market
7.2.1 Europe Cephalosporin Drugs Market by Generation
7.2.1.1 Europe First-Generation Cephalosporin Drugs Market by Country
7.2.1.2 Europe Second-Generation Cephalosporin Drugs Market by Country
7.2.1.3 Europe Third-Generation Cephalosporin Drugs Market by Country
7.2.1.4 Europe Fourth-Generation Cephalosporin Drugs Market by Country
7.2.1.5 Europe Fifth-Generation Cephalosporin Drugs Market by Country
7.2.2 Europe Cephalosporin Drugs Market by Application
7.2.2.1 Europe Respiratory Tract Infection Market by Country
7.2.2.2 Europe Skin Infection Market by Country
7.2.2.3 Europe Ear Infection Market by Country
7.2.2.4 Europe Sexually Transmitted Infection Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Cephalosporin Drugs Market by Route of Administration
7.2.3.1 Europe Injections Market by Country
7.2.3.2 Europe Oral Drugs Market by Country
7.2.4 Europe Cephalosporin Drugs Market by Type
7.2.4.1 Europe Branded Market by Country
7.2.4.2 Europe Generic Market by Country
7.2.5 Europe Cephalosporin Drugs Market by Country
7.2.5.1 Germany Cephalosporin Drugs Market
7.2.5.1.1 Germany Cephalosporin Drugs Market by Generation
7.2.5.1.2 Germany Cephalosporin Drugs Market by Application
7.2.5.1.3 Germany Cephalosporin Drugs Market by Route of Administration
7.2.5.1.4 Germany Cephalosporin Drugs Market by Type
7.2.5.2 UK Cephalosporin Drugs Market
7.2.5.2.1 UK Cephalosporin Drugs Market by Generation
7.2.5.2.2 UK Cephalosporin Drugs Market by Application
7.2.5.2.3 UK Cephalosporin Drugs Market by Route of Administration
7.2.5.2.4 UK Cephalosporin Drugs Market by Type
7.2.5.3 France Cephalosporin Drugs Market
7.2.5.3.1 France Cephalosporin Drugs Market by Generation
7.2.5.3.2 France Cephalosporin Drugs Market by Application
7.2.5.3.3 France Cephalosporin Drugs Market by Route of Administration
7.2.5.3.4 France Cephalosporin Drugs Market by Type
7.2.5.4 Russia Cephalosporin Drugs Market
7.2.5.4.1 Russia Cephalosporin Drugs Market by Generation
7.2.5.4.2 Russia Cephalosporin Drugs Market by Application
7.2.5.4.3 Russia Cephalosporin Drugs Market by Route of Administration
7.2.5.4.4 Russia Cephalosporin Drugs Market by Type
7.2.5.5 Spain Cephalosporin Drugs Market
7.2.5.5.1 Spain Cephalosporin Drugs Market by Generation
7.2.5.5.2 Spain Cephalosporin Drugs Market by Application
7.2.5.5.3 Spain Cephalosporin Drugs Market by Route of Administration
7.2.5.5.4 Spain Cephalosporin Drugs Market by Type
7.2.5.6 Italy Cephalosporin Drugs Market
7.2.5.6.1 Italy Cephalosporin Drugs Market by Generation
7.2.5.6.2 Italy Cephalosporin Drugs Market by Application
7.2.5.6.3 Italy Cephalosporin Drugs Market by Route of Administration
7.2.5.6.4 Italy Cephalosporin Drugs Market by Type
7.2.5.7 Rest of Europe Cephalosporin Drugs Market
7.2.5.7.1 Rest of Europe Cephalosporin Drugs Market by Generation
7.2.5.7.2 Rest of Europe Cephalosporin Drugs Market by Application
7.2.5.7.3 Rest of Europe Cephalosporin Drugs Market by Route of Administration
7.2.5.7.4 Rest of Europe Cephalosporin Drugs Market by Type
7.3 Asia Pacific Cephalosporin Drugs Market
7.3.1 Asia Pacific Cephalosporin Drugs Market by Generation
7.3.1.1 Asia Pacific First-Generation Cephalosporin Drugs Market by Country
7.3.1.2 Asia Pacific Second-Generation Cephalosporin Drugs Market by Country
7.3.1.3 Asia Pacific Third-Generation Cephalosporin Drugs Market by Country
7.3.1.4 Asia Pacific Fourth-Generation Cephalosporin Drugs Market by Country
7.3.1.5 Asia Pacific Fifth-Generation Cephalosporin Drugs Market by Country
7.3.2 Asia Pacific Cephalosporin Drugs Market by Application
7.3.2.1 Asia Pacific Respiratory Tract Infection Market by Country
7.3.2.2 Asia Pacific Skin Infection Market by Country
7.3.2.3 Asia Pacific Ear Infection Market by Country
7.3.2.4 Asia Pacific Sexually Transmitted Infection Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Cephalosporin Drugs Market by Route of Administration
7.3.3.1 Asia Pacific Injections Market by Country
7.3.3.2 Asia Pacific Oral Drugs Market by Country
7.3.4 Asia Pacific Cephalosporin Drugs Market by Type
7.3.4.1 Asia Pacific Branded Market by Country
7.3.4.2 Asia Pacific Generic Market by Country
7.3.5 Asia Pacific Cephalosporin Drugs Market by Country
7.3.5.1 China Cephalosporin Drugs Market
7.3.5.1.1 China Cephalosporin Drugs Market by Generation
7.3.5.1.2 China Cephalosporin Drugs Market by Application
7.3.5.1.3 China Cephalosporin Drugs Market by Route of Administration
7.3.5.1.4 China Cephalosporin Drugs Market by Type
7.3.5.2 Japan Cephalosporin Drugs Market
7.3.5.2.1 Japan Cephalosporin Drugs Market by Generation
7.3.5.2.2 Japan Cephalosporin Drugs Market by Application
7.3.5.2.3 Japan Cephalosporin Drugs Market by Route of Administration
7.3.5.2.4 Japan Cephalosporin Drugs Market by Type
7.3.5.3 India Cephalosporin Drugs Market
7.3.5.3.1 India Cephalosporin Drugs Market by Generation
7.3.5.3.2 India Cephalosporin Drugs Market by Application
7.3.5.3.3 India Cephalosporin Drugs Market by Route of Administration
7.3.5.3.4 India Cephalosporin Drugs Market by Type
7.3.5.4 South Korea Cephalosporin Drugs Market
7.3.5.4.1 South Korea Cephalosporin Drugs Market by Generation
7.3.5.4.2 South Korea Cephalosporin Drugs Market by Application
7.3.5.4.3 South Korea Cephalosporin Drugs Market by Route of Administration
7.3.5.4.4 South Korea Cephalosporin Drugs Market by Type
7.3.5.5 Singapore Cephalosporin Drugs Market
7.3.5.5.1 Singapore Cephalosporin Drugs Market by Generation
7.3.5.5.2 Singapore Cephalosporin Drugs Market by Application
7.3.5.5.3 Singapore Cephalosporin Drugs Market by Route of Administration
7.3.5.5.4 Singapore Cephalosporin Drugs Market by Type
7.3.5.6 Malaysia Cephalosporin Drugs Market
7.3.5.6.1 Malaysia Cephalosporin Drugs Market by Generation
7.3.5.6.2 Malaysia Cephalosporin Drugs Market by Application
7.3.5.6.3 Malaysia Cephalosporin Drugs Market by Route of Administration
7.3.5.6.4 Malaysia Cephalosporin Drugs Market by Type
7.3.5.7 Rest of Asia Pacific Cephalosporin Drugs Market
7.3.5.7.1 Rest of Asia Pacific Cephalosporin Drugs Market by Generation
7.3.5.7.2 Rest of Asia Pacific Cephalosporin Drugs Market by Application
7.3.5.7.3 Rest of Asia Pacific Cephalosporin Drugs Market by Route of Administration
7.3.5.7.4 Rest of Asia Pacific Cephalosporin Drugs Market by Type
7.4 LAMEA Cephalosporin Drugs Market
7.4.1 LAMEA Cephalosporin Drugs Market by Generation
7.4.1.1 LAMEA First-Generation Cephalosporin Drugs Market by Country
7.4.1.2 LAMEA Second-Generation Cephalosporin Drugs Market by Country
7.4.1.3 LAMEA Third-Generation Cephalosporin Drugs Market by Country
7.4.1.4 LAMEA Fourth-Generation Cephalosporin Drugs Market by Country
7.4.1.5 LAMEA Fifth-Generation Cephalosporin Drugs Market by Country
7.4.2 LAMEA Cephalosporin Drugs Market by Application
7.4.2.1 LAMEA Respiratory Tract Infection Market by Country
7.4.2.2 LAMEA Skin Infection Market by Country
7.4.2.3 LAMEA Ear Infection Market by Country
7.4.2.4 LAMEA Sexually Transmitted Infection Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Cephalosporin Drugs Market by Route of Administration
7.4.3.1 LAMEA Injections Market by Country
7.4.3.2 LAMEA Oral Drugs Market by Country
7.4.4 LAMEA Cephalosporin Drugs Market by Type
7.4.4.1 LAMEA Branded Market by Country
7.4.4.2 LAMEA Generic Market by Country
7.4.5 LAMEA Cephalosporin Drugs Market by Country
7.4.5.1 Brazil Cephalosporin Drugs Market
7.4.5.1.1 Brazil Cephalosporin Drugs Market by Generation
7.4.5.1.2 Brazil Cephalosporin Drugs Market by Application
7.4.5.1.3 Brazil Cephalosporin Drugs Market by Route of Administration
7.4.5.1.4 Brazil Cephalosporin Drugs Market by Type
7.4.5.2 Argentina Cephalosporin Drugs Market
7.4.5.2.1 Argentina Cephalosporin Drugs Market by Generation
7.4.5.2.2 Argentina Cephalosporin Drugs Market by Application
7.4.5.2.3 Argentina Cephalosporin Drugs Market by Route of Administration
7.4.5.2.4 Argentina Cephalosporin Drugs Market by Type
7.4.5.3 UAE Cephalosporin Drugs Market
7.4.5.3.1 UAE Cephalosporin Drugs Market by Generation
7.4.5.3.2 UAE Cephalosporin Drugs Market by Application
7.4.5.3.3 UAE Cephalosporin Drugs Market by Route of Administration
7.4.5.3.4 UAE Cephalosporin Drugs Market by Type
7.4.5.4 Saudi Arabia Cephalosporin Drugs Market
7.4.5.4.1 Saudi Arabia Cephalosporin Drugs Market by Generation
7.4.5.4.2 Saudi Arabia Cephalosporin Drugs Market by Application
7.4.5.4.3 Saudi Arabia Cephalosporin Drugs Market by Route of Administration
7.4.5.4.4 Saudi Arabia Cephalosporin Drugs Market by Type
7.4.5.5 South Africa Cephalosporin Drugs Market
7.4.5.5.1 South Africa Cephalosporin Drugs Market by Generation
7.4.5.5.2 South Africa Cephalosporin Drugs Market by Application
7.4.5.5.3 South Africa Cephalosporin Drugs Market by Route of Administration
7.4.5.5.4 South Africa Cephalosporin Drugs Market by Type
7.4.5.6 Nigeria Cephalosporin Drugs Market
7.4.5.6.1 Nigeria Cephalosporin Drugs Market by Generation
7.4.5.6.2 Nigeria Cephalosporin Drugs Market by Application
7.4.5.6.3 Nigeria Cephalosporin Drugs Market by Route of Administration
7.4.5.6.4 Nigeria Cephalosporin Drugs Market by Type
7.4.5.7 Rest of LAMEA Cephalosporin Drugs Market
7.4.5.7.1 Rest of LAMEA Cephalosporin Drugs Market by Generation
7.4.5.7.2 Rest of LAMEA Cephalosporin Drugs Market by Application
7.4.5.7.3 Rest of LAMEA Cephalosporin Drugs Market by Route of Administration
7.4.5.7.4 Rest of LAMEA Cephalosporin Drugs Market by Type
Chapter 8. Company Profiles
8.1 ABBOTT Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaborations, partnerships and agreements:
8.1.1.2 Acquisition and Mergers:
8.2 Teva Pharmaceutical Industries Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product launches:
8.3 Johnson and Johnson
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental &Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 GlaxoSmithKline PLC (GSK)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaborations, partnerships and agreements:
8.4.5.2 Expansion:
8.4.5.3 Approval:
8.5 Pfizer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Collaborations, partnerships and agreements:
8.5.5.2 Product launches:
8.5.5.3 Acquisition and Mergers:
8.6 Merck & Co., Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Collaborations, partnerships and agreements:
8.6.5.2 Product launches:
8.7 Bayer AG (Bayer Schering Pharma AG)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Collaborations, partnerships and agreements:
8.7.5.2 Product launches:
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product launches:
8.9 Bristol-Myers Squibb Company
8.9.1 Company overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Collaborations, partnerships and agreements:
8.1 Novartis AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Product launches:
8.10.5.2 Acquisition and Mergers:



List of Tables


TABLE 1 GLOBAL CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 3 GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 4 GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 5 GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 10 GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 11 GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 16 GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 17 GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 18 GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 19 GLOBAL SKIN INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 GLOBAL SKIN INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 GLOBAL EAR INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 GLOBAL EAR INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 24 GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 25 GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 28 GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 29 GLOBAL INJECTIONS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 GLOBAL INJECTIONS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 GLOBAL ORAL DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 GLOBAL ORAL DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 34 GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 35 GLOBAL BRANDED MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 36 GLOBAL BRANDED MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 37 GLOBAL GENERIC MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 38 GLOBAL GENERIC MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 39 GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 40 GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 41 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 42 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 43 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 44 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 45 NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 46 NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 47 NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 48 NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 49 NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 50 NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 51 NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 52 NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 53 NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 54 NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 55 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 58 NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 59 NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 60 NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 61 NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 62 NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 63 NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 64 NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 65 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 66 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 67 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 68 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 69 NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 70 NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 71 NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 72 NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 73 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 74 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 75 NORTH AMERICA BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 76 NORTH AMERICA BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 77 NORTH AMERICA GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 78 NORTH AMERICA GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 79 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 80 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 81 USA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 82 USA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 83 USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 84 USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 85 USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 88 USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 89 USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 90 USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 91 CANADA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 92 CANADA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 93 CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 94 CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 95 CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 96 CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 97 CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 98 CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 99 CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 100 CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 101 MEXICO CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 102 MEXICO CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 103 MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 104 MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 105 MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 106 MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 107 MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 108 MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 109 MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 110 MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 111 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 112 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 113 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 114 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 115 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 116 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 117 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 118 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 119 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 120 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 121 EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 122 EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 123 EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 124 EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 125 EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 126 EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 127 EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 128 EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 129 EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 130 EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 131 EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 132 EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 133 EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 134 EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 135 EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 136 EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 137 EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 138 EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 139 EUROPE SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 140 EUROPE SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 141 EUROPE EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 142 EUROPE EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 143 EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 144 EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 145 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 146 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 147 EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 148 EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 149 EUROPE INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 150 EUROPE INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 151 EUROPE ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 152 EUROPE ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 153 EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 154 EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 155 EUROPE BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 156 EUROPE BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 157 EUROPE GENERIC MARKET BY COUNTRY, 2015 - 2018,USD MILLION
TABLE 158 EUROPE GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 159 EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 160 EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 161 GERMANY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 162 GERMANY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 163 GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 164 GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 165 GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 166 GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 167 GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 168 GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 169 GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 170 GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 171 UK CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 172 UK CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 173 UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 174 UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 175 UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 176 UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 177 UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 178 UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 179 UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 180 UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 181 FRANCE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 182 FRANCE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 183 FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 184 FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 185 FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 186 FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 187 FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 188 FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 189 FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 190 FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 191 RUSSIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 192 RUSSIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 193 RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 194 RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 195 RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 196 RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 197 RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 198 RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 199 RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 200 RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 201 SPAIN CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 202 SPAIN CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 203 SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 204 SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 205 SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 206 SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 207 SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 208 SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 209 SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 210 SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 211 ITALY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 212 ITALY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 213 ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 214 ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 215 ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 216 ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 217 ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 218 ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 219 ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 220 ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 221 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 222 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 223 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 224 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 225 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 226 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 227 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 228 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 229 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 230 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 231 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 232 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 233 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 234 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 235 ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 236 ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 237 ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 238 ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 239 ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 240 ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 241 ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 242 ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 243 ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 244 ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 245 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 246 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 247 ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 248 ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 249 ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 250 ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 251 ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 252 ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 255 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET, 2015 - 2018, USD MILLION
TABLE 256 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET, 2019 - 2025, USD MILLION
TABLE 257 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 258 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 259 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET BY INDUSTRY, 2015 - 2018, USD MILLION
TABLE 260 REST OF LAMEA AUTOMATIC LABELING MACHINE MARKET BY INDUSTRY, 2019 - 2025, USD MILLION
TABLE 261 KEY INFORMATION –THE KRONES GROUP
TABLE 262 KEY INFORMATION – MPI LABEL SYSTEMS, INC.
TABLE 263 KEY INFORMATION – SALZGITTER AG
TABLE 264 KEY INFORMATION - FUJI SEAL INTERNATIONAL, INC.
TABLE 265 KEY INFORMATION – PROMACH INC.
TABLE 266 KEY INFORMATION – MARCHESINI GROUP S.P.A.
TABLE 267 KEY INFORMATION – IMA GROUP
TABLE 268 KEY INFORMATION – ACCUTEK PACKAGING EQUIPMENT COMPANIES, INC.
TABLE 269 KEY INFORMATION – BARRY-WEHMILLER GROUP, INC.
TABLE 270 KEY INFORMATION – NEWMAN LABELLING SYSTEMS LTD.
LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY TYPE, 2015 - 2018, USD MILLION
FIG 3 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY TYPE, 2019 - 2025, USD MILLION
FIG 4 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY INDUSTRY, 2015 - 2018, USD MILLION
FIG 5 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY INDUSTRY, 2019 - 2025, USD MILLION
FIG 6 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY REGION, 2015 - 2018, USD MILLION
FIG 7 GLOBAL AUTOMATIC LABELING MACHINE MARKET BY REGION, 2019 - 2025, USD MILLION
FIG 8 SWOT ANALYSIS: THE KRONES GROUP
FIG 9 SWOT ANALYSIS: SALZGITTER AG
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: PROMACH INC.
FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: IMA GROUP
ATION SIZE, 2015 - 2018, USD MILLION
TABLE 257 CHINA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 258 CHINA APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 259 CHINA APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 260 JAPAN APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 261 JAPAN APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 262 JAPAN APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 263 JAPAN APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 264 JAPAN APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 265 JAPAN APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 266 JAPAN APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 267 JAPAN APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 268 INDIA APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 269 INDIA APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 270 INDIA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 271 INDIA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 272 INDIA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 273 INDIA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 274 INDIA APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 275 INDIA APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 276 SOUTH KOREA APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 277 SOUTH KOREA APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 278 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 279 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 280 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 281 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 282 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 283 SOUTH KOREA APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 284 SINGAPORE APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 285 SINGAPORE APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 286 SINGAPORE APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 287 SINGAPORE APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 288 SINGAPORE APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 289 SINGAPORE APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 290 SINGAPORE APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 291 SINGAPORE APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 292 MALAYSIA APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 293 MALAYSIA APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 294 MALAYSIA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 295 MALAYSIA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 296 MALAYSIA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 297 MALAYSIA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 298 MALAYSIA APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 299 MALAYSIA APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 300 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 301 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 302 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 303 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 304 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 305 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 306 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 307 REST OF ASIA PACIFIC APPLICATION TRANSFORMATION MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 308 LAMEA APPLICATION TRANSFORMATION MARKET, 2015 - 2018, USD MILLION
TABLE 309 LAMEA APPLICATION TRANSFORMATION MARKET, 2019 - 2025, USD MILLION
TABLE 310 LAMEA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2015 - 2018, USD MILLION
TABLE 311 LAMEA APPLICATION TRANSFORMATION MARKET BY SERVICES TYPE, 2019 - 2025, USD MILLION
TABLE 312 LAMEA APPLICATION INTEGRATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 313 LAMEA APPLICATION INTEGRATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 314 LAMEA CLOUD APPLICATION MIGRATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 315 LAMEA CLOUD APPLICATION MIGRATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 316 LAMEA APPLICATION PORTFOLIO ASSESSMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 317 LAMEA APPLICATION PORTFOLIO ASSESSMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 318 LAMEA APPLICATION REPLATFORMING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 319 LAMEA APPLICATION REPLATFORMING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 320 LAMEA APPLICATION TRANSFORMATION UI MODERNIZATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 321 LAMEA APPLICATION TRANSFORMATION UI MODERNIZATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 322 LAMEA OTHER SERVICES TYPE APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 323 LAMEA OTHER SERVICES TYPE APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 324 LAMEA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2015 - 2018, USD MILLION
TABLE 325 LAMEA APPLICATION TRANSFORMATION MARKET BY ORGANIZATION SIZE, 2019 - 2025, USD MILLION
TABLE 326 LAMEA LARGE ENTERPRISES APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 327 LAMEA LARGE ENTERPRISES APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 328 LAMEA SMALL & MEDIUM-SIZED ENTERPRISES APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 329 LAMEA SMALL & MEDIUM-SIZED ENTERPRISES APPLICATION TRANSFORMATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 330 LAMEA APPLICATION TRANSFORMATION MARKET BY END USER, 2015 - 2018, USD MILLION